Abstract |
High dose interferon treatment for 1 year is the only established treatment for chronic hepatitis D, but it is associated with a high relapse rate after treatment discontinuation. In this study, patients were treated with 10 MU interferon alpha 2b, thrice weekly for 2 years. Twenty-three patients were recruited and 15 completed the 2-year treatment and 6 months follow-up periods. Treatment response was assessed biochemically [normal alanine aminotransferase (ALT)], virologically (undetectable hepatitis D virus RNA) and histologically (at least 2 point decrease in the Knodell score) at the end of treatment (EOT) and at the end of follow-up. Out of 15 patients who finished the 2-year treatment period, seven patients (47%) had a biochemical response but only two (13%) had a normal ALT after follow-up. ALT decreased from the baseline value of 143.1 +/- 121.7 (mean +/- SD) to 39.7 +/- 20.6 (P < 0.01) at EOT. Virological response was observed in six patients at EOT and in two patients at follow-up. Two patients lost hepatitis B surface antigen. Of the 12 patients with paired liver biopsies, a histological improvement was observed in eight patients. Interferon treatment leads to a complete or partial response in a substantial number of patients but 2 years of treatment does not appear to increase sustained response rates over 1 year treatment.
|
Authors | C Yurdaydin, H Bozkaya, H Karaaslan, F O Onder, O E Erkan, K Yalçin, H Değertekin, A M Bozdayi, O Uzunalimoğlu |
Journal | Journal of viral hepatitis
(J Viral Hepat)
Vol. 14
Issue 11
Pg. 812-6
(Nov 2007)
ISSN: 1352-0504 [Print] England |
PMID | 17927618
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Antiviral Agents
- Interferon alpha-2
- Interferon-alpha
- RNA, Viral
- Recombinant Proteins
- Alanine Transaminase
|
Topics |
- Adult
- Alanine Transaminase
(blood)
- Antiviral Agents
(therapeutic use)
- Biopsy
- Female
- Hepatitis D
(drug therapy, enzymology, pathology, virology)
- Hepatitis Delta Virus
(growth & development)
- Histocytochemistry
- Humans
- Interferon alpha-2
- Interferon-alpha
(therapeutic use)
- Male
- Pilot Projects
- RNA, Viral
(blood, chemistry, genetics)
- Recombinant Proteins
- Reverse Transcriptase Polymerase Chain Reaction
|